Reese Pharmaceutical, a privately held manufacturer of over-the-counter (OTC) branded and private label products today announced ColoTest®, its new Fecal Immunochemical Test (FIT) for colon cancer screening, is now available at 3,700 Walmart locations across the U.S.
The FDA-cleared ColoTest® identifies the presence of hidden blood in the stool in support of the early detection of colon cancer or gastrointestinal disorders such as colitis, diverticulitis, and polyps. Launched in February 2024, it is now available in thousands of retail locations as well as online at Walmart.com.
A store locator provides consumers access to the location nearest them at mycolotest.com/store-locator/.
